Contact this trialFirst, we need to learn more about you.
ATR Kinase Inhibitor
Adavosertib + Olaparib for Recurrent Ovarian Cancer
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing adavosertib with or without olaparib to treat patients with ovarian, primary peritoneal, or fallopian tube cancer that has come back.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.